U.S. safety records, as the agencies wrote them. Independent.
FDA · Animal and veterinary recall

Proin ER…

Recall started · FDA enforcement report Aug. 5, 2026 Class II

Reason
Failed dissolution specifications
Status
Ongoing
Distribution
Nationwide

This box checks this one record only. Other recalls of the same product or company are on the brand page.

Enforcement report date
Aug. 5, 2026
Risk class
Class II (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote)
Status
Ongoing (FDA's definition: a recall which is currently in progress; as in FDA's Enforcement Report data of the last download)
Filed by
Pegasus Laboratories, Inc.
Product
Proin ER, phenylpropanolamine hydrochloride extended-release tablets, 145mg Tablets, Net Contents 30 Tablets, Manufactured by: Pegasus Laboratories, Inc., Employee-owned Pensacola, FL 32514, USA, NDC 49427-347-57, for use in dogs
Reason
Failed dissolution specifications
Distribution pattern
Nationwide
Quantity
7,248 bottles
Codes and lots
Lot# 25108A1
Recall started
July 20, 2026
Voluntary or mandated
Voluntary: Firm Initiated
Recall number
V-0183-2026

What the record says about this drug

A simplified drawing of a vial, following the words of FDA's record. It shows the reason the record gives, not a photograph of the product.

Four steps: a container, the reason the record gives, the record's wordsA simplified drawing of a drug's container with a mark for the reason the record gives. Left, for comparison: the same drawing without what the record names. Right: this record.1 The product: Proin ER, phenylpropanolamine…2 The record names a potency or dissolution failure3 What the record says4 What the record listsFOR COMPARISONthe same drawing, withoutwhat the record namesTHIS RECORDwhat the record names,step by stepFailed dissolution specifications

“Failed dissolution specifications”Proin ER, phenylpropanolamine hydrochloride extended-release tablets, 145mg Tablets, Net Contents 30 Tablets, Manufactured by: Pegasus Laboratories, Inc., Employee-owned Pensacola, FL 32514, USA, NDC 49427-347-57, for use in dogs, FDA veterinary enforcement report, 2026-08-05. The caption is the record's own words.

A generic vial, not the product. The mark follows the record's own words (a question mark, where used, stands for a lack of assurance the record names, not for anything found).

If the drawing and the record's words differ, the words govern. A drawing is chosen by rules and an AI reading of the record and can miss what it means; report one with the form below.

This recall among the others

  • FDA's enforcement report came 16 days after the firm started the recall. For half of the 60 FDA veterinary recall events reported in 2026 so far with a start date, it took 21 days or fewer (by year).
  • Pegasus Laboratories: 4 other recalls or notices on this site in the three years before this one (from Aug. 6, 2023).

Counted from the agency records on this site, as on Statistics: a recall event once, by its first notice.

What should I do? Pet food recall: what to do · How to read this record

Source: FDA · Animal and veterinary enforcement report, recall number V-0183-2026. See this record in FDA's Enforcement Report. The agency record governs; check it and the company before acting.

Cite this record
FDA recall record V-0183-2026, Aug. 5, 2026. "Proin ER." PlainRecords, https://plainrecords.com/recall/vet/v-0183-2026/ (as of the day it was built).

At each build a sample of records from each source is compared with the agency's published file and the page; every correction is public. Drawings are chosen by software that reads the record. Built daily. How we check · Corrections

Report a mistake on this page

Newest pet and animal recalls from other companies

Check another brand or product

Recalled in the last 7 days: Game Changer Products · Eros Apothecary · Cummins (company) · Huffy · QIOMALA · SHEIN Distribution · Allstar Marketing Group · Arrow Reliance